413 related articles for article (PubMed ID: 4055265)
1. Clinical value of serum amyloid A and C-reactive protein measurements in secondary amyloidosis.
Maury CP; Wegelius O
Int J Tissue React; 1985; 7(5):405-7. PubMed ID: 4055265
[TBL] [Abstract][Full Text] [Related]
2. Increased circulating serum amyloid A protein derivatives in rheumatoid arthritis patients with secondary amyloidosis.
Migita K; Eguchi K; Tsukada T; Kawabe Y; Takashima H; Mine M; Aoyagi T; Ichinose Y; Nagataki S
Lab Invest; 1996 Sep; 75(3):371-5. PubMed ID: 8804360
[TBL] [Abstract][Full Text] [Related]
3. Rheumatoid arthritis exhibits reduced acute phase and enhanced constitutive serum amyloid A protein in synovial fluid relative to serum. A comparison with C-reactive protein.
Kumon Y; Loose LD; Birbara CA; Sipe JD
J Rheumatol; 1997 Jan; 24(1):14-9. PubMed ID: 9002005
[TBL] [Abstract][Full Text] [Related]
4. [Inflammatory reaction and laboratory tests: serum amyloid A (SAA) protein].
Yamada T
Rinsho Byori; 1990 Mar; 38(3):249-54. PubMed ID: 2112209
[TBL] [Abstract][Full Text] [Related]
5. Serum amyloid A in the assessment of early inflammatory arthritis.
Cunnane G; Grehan S; Geoghegan S; McCormack C; Shields D; Whitehead AS; Bresnihan B; Fitzgerald O
J Rheumatol; 2000 Jan; 27(1):58-63. PubMed ID: 10648018
[TBL] [Abstract][Full Text] [Related]
6. Serum amyloid P component levels are not decreased in patients with systemic lupus erythematosus and do not rise during an acute phase reaction.
Bijl M; Bootsma H; Van Der Geld Y; Limburg PC; Kallenberg CG; Van Rijswijk MH
Ann Rheum Dis; 2004 Jul; 63(7):831-5. PubMed ID: 15194579
[TBL] [Abstract][Full Text] [Related]
7. Nephelometric measurement of human serum prealbumin and correlation with acute-phase proteins CRP and SAA: results in familial amyloid polyneuropathy.
Connors LH; Gertz MA; Skinner M; Cohen AS
J Lab Clin Med; 1984 Oct; 104(4):538-45. PubMed ID: 6090552
[TBL] [Abstract][Full Text] [Related]
8. Serum amyloid-A protein concentration in inflammatory diseases and its relationship to the incidence of reactive systemic amyloidosis.
De Beer FC; Mallya RK; Fagan EA; Lanham JG; Hughes GR; Pepys MB
Lancet; 1982 Jul; 2(8292):231-4. PubMed ID: 6124669
[TBL] [Abstract][Full Text] [Related]
9. Changes in human serum amyloid A and C-reactive protein after etiocholanolone-induced inflammation.
McAdam KP; Elin RJ; Sipe JD; Wolff SM
J Clin Invest; 1978 Feb; 61(2):390-4. PubMed ID: 621279
[TBL] [Abstract][Full Text] [Related]
10. Serum amyloid A protein and C-reactive protein in systemic amyloidosis.
Gertz MA; Skinner M; Sipe JD; Cohen AS; Kyle RA
Clin Exp Rheumatol; 1985; 3(4):317-20. PubMed ID: 4085162
[TBL] [Abstract][Full Text] [Related]
11. Serum amyloid A (SAA) concentration varies among rheumatoid arthritis patients estimated by SAA/CRP ratio.
Kokubun M; Imafuku Y; Okada M; Ohguchi Y; Ashikawa T; Yamada T; Yoshida H
Clin Chim Acta; 2005 Oct; 360(1-2):97-102. PubMed ID: 15932751
[TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor alpha, its soluble receptor I, and -308 gene promoter polymorphism in patients with rheumatoid arthritis with or without amyloidosis: implications for the pathogenesis of nephropathy and anemia of chronic disease in reactive amyloidosis.
Maury CP; Liljeström M; Laiho K; Tiitinen S; Kaarela K; Hurme M
Arthritis Rheum; 2003 Nov; 48(11):3068-76. PubMed ID: 14613268
[TBL] [Abstract][Full Text] [Related]
13. Increased serum amyloid a levels reflect colitis severity and precede amyloid formation in IL-2 knockout mice.
de Villiers WJ; Varilek GW; de Beer FC; Guo JT; Kindy MS
Cytokine; 2000 Sep; 12(9):1337-47. PubMed ID: 10975993
[TBL] [Abstract][Full Text] [Related]
14. Characterization of amyloid related protein SAA complexed with serum lipoproteins (apoSAA).
Marhaug G; Sletten K; Husby G
Clin Exp Immunol; 1982 Nov; 50(2):382-9. PubMed ID: 7151331
[TBL] [Abstract][Full Text] [Related]
15. Serum amyloid protein SAA, C-reactive protein and lysozyme in leprosy.
Scheinberg MA; Masuda A; Benson MD; Mendes NF
Int J Lepr Other Mycobact Dis; 1979 Jun; 47(2):133-7. PubMed ID: 572349
[TBL] [Abstract][Full Text] [Related]
16. Serum and synovial fluid levels of serum amyloid A protein and C-reactive protein in inflammatory and noninflammatory arthritis.
Sukenik S; Henkin J; Zimlichman S; Skibin A; Neuman L; Pras M; Horowitz J; Shainkin-Kestenbaum R
J Rheumatol; 1988 Jun; 15(6):942-5. PubMed ID: 3418644
[TBL] [Abstract][Full Text] [Related]
17. Serum amyloid A protein in amyloidosis, rheumatic, and enoplastic diseases.
Benson MD; Cohen AS
Arthritis Rheum; 1979 Jan; 22(1):36-42. PubMed ID: 103558
[TBL] [Abstract][Full Text] [Related]
18. [Quantitative levels of serum amyloid A protein and other proteins in cerebrospinal fluid and serum of patients with meningitis].
Shimetani N; Ichikawa K; Shibuya M; Mashiko T; Matsuyama N; Kanoh Y; Ohtani H
Rinsho Byori; 1998 Sep; 46(9):930-5. PubMed ID: 9800479
[TBL] [Abstract][Full Text] [Related]
19. Influence of Serum Amyloid A (SAA1) and SAA2 gene polymorphisms on renal amyloidosis, and on SAA/C-reactive protein values in patients with familial mediterranean fever in the Turkish population.
Bakkaloglu A; Duzova A; Ozen S; Balci B; Besbas N; Topaloglu R; Ozaltin F; Yilmaz E
J Rheumatol; 2004 Jun; 31(6):1139-42. PubMed ID: 15170927
[TBL] [Abstract][Full Text] [Related]
20. Cystatin C binds serum amyloid A, downregulating its cytokine-generating properties.
Bokarewa M; Abrahamson M; Levshin N; Egesten A; Grubb A; Dahlberg L; Tarkowski A
J Rheumatol; 2007 Jun; 34(6):1293-301. PubMed ID: 17552057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
